DNA-Encoded Libraries Platforms and Services Market By Offerings (DEL-Driven Hit identification, Hit-to-Lead, Lead Optimization, Libraries design & production, Screening & data analysis and Others); By End-Users (Pharmaceutical Companies, Biotechs, Research Institutions, Others); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 - 2029
Industry Trends
Rising prevalence of diseases and the need for faster mode of treatments is accelerating the development of pharmaceutical drugs. DNA - encoded libraries also known as DELs is a sophisticated combinatorial drug discovery tool for synthesis and screening of large collections of small molecule compounds. The automated screening of small organic ligands using DNA- encoded chemical libraries has enabled identification of potential lead molecules. These lead molecules are selected from refining the collection of hits for further development. This technology is a prominent approach to early stage drug discovery. Traditional methods used for DNA screening are lengthy and time consuming where compounds are tested individually over months, as opposed to traditional methods DEL allows huge number of compounds to be simultaneously interrogated in less time. It has the capacity to store billions or even trillions of compounds that can fit into a space size of an eppendorf tube. This technology prevails higher probability of finding a useful compound with good properties and a tractable route for future medical drug discoveries. Major pharmaceutical corporations have embraced a DNA-encoded chemical library (DEL) and are using it in a variety of drug discovery projects. Due to reduced cost, time, and storage space required for the identification of target compounds, DEL is one of the most useful techniques during the early stages of drug research, thus creating huge growth opportunities for DNA-encoded libraries platforms and services market.
In the pharmaceutical sector, DNA-encoded library (DEL) technology is developed as a new screening technique for exploring undiscovered chemical area. In pharmaceutical settings, DNA-encoded library (DEL) technology has recently emerged as a new screening technique for quick discovery of medicinal candidates. This technology enables the assembly and interrogation of billions of small organic ligands against a biological target in a single experiment at a low cost and in a short amount of time. DNA-encoded libraries (DEL) have matured into a major technology platform for ligand discovery in the pharmaceutical industry. The explosive growth of DEL-compatible chemistries has greatly improved DEL chemical diversity and fuelled its applications in drug discovery. These factors are driving the demand of DNA-encoded libraries platforms and services market.
The COVID-19 pandemic has impacted business operations across the globe. Remote working options are being provided by numerous companies to enable social in distancing. The COVID-19 pandemic is exhibiting a positive impact on global DNA-encoded libraries platforms and services market. Major companies are collaborating and coming up solutions/services/drugs with an aim to fight COVID-19 virus. For instance, in April 2021, X-Chem, Inc., Arbutus Biopharma Corporation, and Proteros biostructures GmbH declared that they had entered into a discovery research and license agreement. This aim of this agreement was focused on the detection of novel inhibitors targeting the SARS-CoV-2 nsp5 main protease (Mpro). X-Chem’s industry leading DNA-encoded library (DEL) technology along with Arbutus expertise in the detection and development of antiviral agents and Proteros’s protein sciences, will aid in finding potential, safe and effective therapies to fight against coronavirus.
Thus, various major pharmaceutical companies are entering into a partnership/collaborating to meet the unmet needs of healthcare industry.
In terms of revenue, global DNA-encoded libraries platforms and services market was valued at US$ 719.04 Mn in 2020 and is anticipated to reach US$ 4043.80 Mn by 2029 growing at a CAGR of 21.27% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global DNA-Encoded Libraries Platforms and Services Market Revenue & Forecast, (US$ Million), 2015 – 2029
Offerings Outlook:
Based on the offerings, the global DNA-encoded libraries platforms and services market is segmented into del-driven hit identification, hit-to-lead, lead optimization, libraries design & production, screening & data analysis and others. Libraries design & production segment accounted for the major market share in 2020. However, hit-to-lead segment is expected to grow at the fastest rate over the forecast period.
End-Users Outlook:
Based on the offerings, the global DNA-encoded libraries platforms and services market is segmented into pharmaceutical companies, biotechs, research institutions and others. Pharmaceutical companies accounted for the highest market share in the global DNA encoded libraries platforms and services market in 2020 as far as the end-user segment is concerned. Rising demand for the development of drugs to fight against numerous illnesses that is threatening life on earth is a reason for the greater share of pharmaceutical companies. Furthermore, companies are investing heavily in research and development activities as well as collaborating with academic research institutes for DNA encoded libraries. For instance, HitGen Inc. entered into a research collaboration agreement with Dorian Therapeutics, Inc., to discover compounds and screening of DNA that are of interest to company. These factors have aided in the growth of this segment.
Region Outlook:
Based on the regions, Europe accounted for the highest share in the global DNA-encoded libraries platforms and services market in 2020. The presence of prominent DNA encoded libraries platforms and services providers in countries /regions such as the Germany, Scandinavia, the UK, etc., coupled with the presence of a number of pharmaceutical companies in Europe that are focussing on the development of new drugs is a major reason for the greater share of Europe in the global DNA-encoded libraries platforms and services market.
Competitive Landscape
The report provides both, qualitative and quantitative research of DNA-encoded libraries platforms and services market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the DNA-encoded libraries platforms and services market are Amgen Inc., X-Chem, NovAliX, BOC Sciences, SpiroChem, DyNAbind GmbH, Vipergen ApS, Novartis AG, WuXi AppTec, HitGen Inc and LGC Biosearch Technologies amongst others.
Global DNA-Encoded Libraries Platforms and Services Market:
By Offerings
- DEL-Driven Hit identification
- Hit-to-Lead
- Lead Optimization
- Libraries design & production
- Screening & data analysis
- Others
By End-Users
- Pharmaceutical Companies
- Biotechs
- Research Institutions
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1.Market
Segmentation
1.2.Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1.Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3.Market Size
Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4.Data
Triangulation Methodology
3.5.Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of DNA-Encoded Libraries Platforms and
Services Market
6. Market Synopsis:
DNA-Encoded Libraries Platforms and Services Market
7. DNA-Encoded Libraries Platforms and Services Market Analysis:
Qualitative Perspective
7.1.Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2.Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3.Trends in
DNA-Encoded Libraries Platforms and Services Market
7.4.Market
Determinants Radar Chart
7.5.Macro-Economic
and Micro-Economic Indicators: DNA-Encoded Libraries Platforms and Services
Market
7.6.Impact of
Covid-19 on DNA-Encoded Libraries Platforms and Services Market
8. Global DNA-Encoded Libraries Platforms and Services Market
Analysis and Forecasts, 2021 – 2029
8.1.Overview
8.1.1. Global
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
8.2.Global
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
8.2.1. EL-Driven
Hit identification
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 - 2020
8.2.1.3. Market
Forecast, 2021 - 2029
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2020
8.2.1.5.1.2. Market Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2020
8.2.1.5.2.2. Market Forecast, 2021 - 2029
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2020
8.2.1.5.3.2. Market Forecast, 2021 - 2029
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2020
8.2.1.5.4.2. Market Forecast, 2021 - 2029
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2020
8.2.1.5.5.2. Market Forecast, 2021 - 2029
8.2.2. Hit-to-Lead
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 - 2020
8.2.2.3. Market
Forecast, 2021 - 2029
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2020
8.2.2.5.1.2. Market Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2020
8.2.2.5.2.2. Market Forecast, 2021 - 2029
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2020
8.2.2.5.3.2. Market Forecast, 2021 - 2029
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2020
8.2.2.5.4.2. Market Forecast, 2021 - 2029
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2020
8.2.2.5.5.2. Market Forecast, 2021 - 2029
8.2.3. Lead
Optimization
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 - 2020
8.2.3.3. Market
Forecast, 2021 - 2029
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2020
8.2.3.5.1.2. Market Forecast, 2021 - 2029
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2020
8.2.3.5.2.2. Market Forecast, 2021 - 2029
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2020
8.2.3.5.3.2. Market Forecast, 2021 - 2029
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2020
8.2.3.5.4.2. Market Forecast, 2021 - 2029
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2020
8.2.3.5.5.2. Market Forecast, 2021 - 2029
8.2.4. Libraries
design and production
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 - 2020
8.2.4.3. Market
Forecast, 2021 - 2029
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2020
8.2.4.5.1.2. Market Forecast, 2021 - 2029
8.2.4.5.2. Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2020
8.2.4.5.2.2. Market Forecast, 2021 - 2029
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2020
8.2.4.5.3.2. Market Forecast, 2021 - 2029
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2020
8.2.4.5.4.2. Market Forecast, 2021 - 2029
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2020
8.2.4.5.5.2. Market Forecast, 2021 - 2029
8.2.5. Screening
and data analysis
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 - 2020
8.2.5.3. Market
Forecast, 2021 - 2029
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market Estimation, 2015 - 2020
8.2.5.5.1.2. Market Forecast, 2021 - 2029
8.2.5.5.2. Europe
8.2.5.5.2.1. Market Estimation, 2015 - 2020
8.2.5.5.2.2. Market Forecast, 2021 - 2029
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market Estimation, 2015 - 2020
8.2.5.5.3.2. Market Forecast, 2021 - 2029
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market Estimation, 2015 - 2020
8.2.5.5.4.2. Market Forecast, 2021 - 2029
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market Estimation, 2015 - 2020
8.2.5.5.5.2. Market Forecast, 2021 - 2029
8.2.6. Others
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 - 2020
8.2.6.3. Market
Forecast, 2021 - 2029
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market Estimation, 2015 - 2020
8.2.6.5.1.2. Market Forecast, 2021 - 2029
8.2.6.5.2. Europe
8.2.6.5.2.1. Market Estimation, 2015 - 2020
8.2.6.5.2.2. Market Forecast, 2021 - 2029
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market Estimation, 2015 - 2020
8.2.6.5.3.2. Market Forecast, 2021 - 2029
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market Estimation, 2015 - 2020
8.2.6.5.4.2. Market Forecast, 2021 - 2029
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market Estimation, 2015 - 2020
8.2.6.5.5.2. Market Forecast, 2021 - 2029
8.3.Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global DNA-Encoded Libraries Platforms and Services Market
Analysis and Forecasts, 2021 – 2029
9.1.Overview
9.2.Global
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
9.2.1. Pharmaceutical
Companies
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 - 2020
9.2.1.3. Market
Forecast, 2021 - 2029
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2020
9.2.1.5.1.2. Market Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2020
9.2.1.5.2.2. Market Forecast, 2021 - 2029
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2020
9.2.1.5.3.2. Market Forecast, 2021 - 2029
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2020
9.2.1.5.4.2. Market Forecast, 2021 - 2029
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2020
9.2.1.5.5.2. Market Forecast, 2021 - 2029
9.2.2. Biotechs
9.2.2.1. Definition
9.2.2.2. Market
Estimation and Penetration, 2015 - 2020
9.2.2.3. Market
Forecast, 2021 - 2029
9.2.2.4. Compound
Annual Growth Rate (CAGR)
9.2.2.5. Regional
Bifurcation
9.2.2.5.1. North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2020
9.2.2.5.1.2. Market Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2020
9.2.2.5.2.2. Market Forecast, 2021 - 2029
9.2.2.5.3. Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2020
9.2.2.5.3.2. Market Forecast, 2021 - 2029
9.2.2.5.4. Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2020
9.2.2.5.4.2. Market Forecast, 2021 - 2029
9.2.2.5.5. Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2020
9.2.2.5.5.2. Market Forecast, 2021 - 2029
9.2.3. Research
Institutions
9.2.3.1. Definition
9.2.3.2. Market
Estimation and Penetration, 2015 - 2020
9.2.3.3. Market
Forecast, 2021 - 2029
9.2.3.4. Compound
Annual Growth Rate (CAGR)
9.2.3.5. Regional
Bifurcation
9.2.3.5.1. North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2020
9.2.3.5.1.2. Market Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2020
9.2.3.5.2.2. Market Forecast, 2021 - 2029
9.2.3.5.3. Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2020
9.2.3.5.3.2. Market Forecast, 2021 - 2029
9.2.3.5.4. Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2020
9.2.3.5.4.2. Market Forecast, 2021 - 2029
9.2.3.5.5. Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2020
9.2.3.5.5.2. Market Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market
Estimation and Penetration, 2015 - 2020
9.2.4.3. Market
Forecast, 2021 - 2029
9.2.4.4. Compound
Annual Growth Rate (CAGR)
9.2.4.5. Regional
Bifurcation
9.2.4.5.1. North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2020
9.2.4.5.1.2. Market Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2020
9.2.4.5.2.2. Market Forecast, 2021 - 2029
9.2.4.5.3. Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2020
9.2.4.5.3.2. Market Forecast, 2021 - 2029
9.2.4.5.4. Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2020
9.2.4.5.4.2. Market Forecast, 2021 - 2029
9.2.4.5.5. Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2020
9.2.4.5.5.2. Market Forecast, 2021 - 2029
9.3.Key
Segment for Channeling Investments
9.3.1. By
End-Users
10. North America DNA-Encoded Libraries Platforms and Services
Market Analysis and Forecasts, 2021 - 2029
10.1.Overview
10.1.1. North
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
10.2.North
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
10.2.1. DEL-Driven
Hit identification
10.2.2. Hit-to-Lead
10.2.3. Lead
Optimization
10.2.4. Libraries
design and production
10.2.5. Screening
and data analysis
10.2.6. Others
10.3.North
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
10.3.1. Pharmaceutical
Companies
10.3.2. Biotechs
10.3.3. Research
Institutions
10.3.4. Others
10.4.North
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
10.4.1.1.1. DEL-Driven
Hit identification
10.4.1.1.2. Hit-to-Lead
10.4.1.1.3. Lead
Optimization
10.4.1.1.4. Libraries
design and production
10.4.1.1.5. Screening
and data analysis
10.4.1.1.6. Others
10.4.1.2. U.S
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
10.4.1.2.1. Pharmaceutical
Companies
10.4.1.2.2. Biotechs
10.4.1.2.3. Research
Institutions
10.4.1.2.4. Others
10.4.2. Canada
10.4.2.1. Canada
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
10.4.2.1.1. DEL-Driven
Hit identification
10.4.2.1.2. Hit-to-Lead
10.4.2.1.3. Lead
Optimization
10.4.2.1.4. Libraries
design and production
10.4.2.1.5. Screening
and data analysis
10.4.2.1.6. Others
10.4.2.2. Canada
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
10.4.2.2.1. Pharmaceutical
Companies
10.4.2.2.2. Biotechs
10.4.2.2.3. Research
Institutions
10.4.2.2.4. Others
10.4.3. Mexico
10.4.3.1. Mexico
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and Forecasts,
By Offerings
10.4.3.1.1. DEL-Driven
Hit identification
10.4.3.1.2. Hit-to-Lead
10.4.3.1.3. Lead
Optimization
10.4.3.1.4. Libraries
design and production
10.4.3.1.5. Screening
and data analysis
10.4.3.1.6. Others
10.4.3.2. Mexico
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
10.4.3.2.1. Pharmaceutical
Companies
10.4.3.2.2. Biotechs
10.4.3.2.3. Research
Institutions
10.4.3.2.4. Others
10.4.4. Rest of
North America
10.4.4.1. Rest
of North America DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By Offerings
10.4.4.1.1. DEL-Driven
Hit identification
10.4.4.1.2. Hit-to-Lead
10.4.4.1.3. Lead
Optimization
10.4.4.1.4. Libraries
design and production
10.4.4.1.5. Screening
and data analysis
10.4.4.1.6. Others
10.4.4.2. Rest
of North America DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By End-Users
10.4.4.2.1. Pharmaceutical
Companies
10.4.4.2.2. Biotechs
10.4.4.2.3. Research
Institutions
10.4.4.2.4. Others
10.5.Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Offerings
10.5.3. By
End-Users
11. Europe DNA-Encoded Libraries Platforms and Services Market
Analysis and Forecasts, 2021 - 2029
11.1.Overview
11.1.1. Europe
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
11.2.Europe
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.2.1. DEL-Driven
Hit identification
11.2.2. Hit-to-Lead
11.2.3. Lead
Optimization
11.2.4. Libraries
design and production
11.2.5. Screening
and data analysis
11.2.6. Others
11.3.Europe DNA-Encoded
Libraries Platforms and Services Market Revenue (US$ Mn) and Forecasts, By
End-Users
11.3.1. Pharmaceutical
Companies
11.3.2. Biotechs
11.3.3. Research
Institutions
11.3.4. Others
11.4.Europe
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.1. France
11.4.1.1. France
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.4.1.1.1. DEL-Driven
Hit identification
11.4.1.1.2. Hit-to-Lead
11.4.1.1.3. Lead
Optimization
11.4.1.1.4. Libraries
design and production
11.4.1.1.5. Screening
and data analysis
11.4.1.1.6. Others
11.4.1.2. France
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.1.2.1. Pharmaceutical
Companies
11.4.1.2.2. Biotechs
11.4.1.2.3. Research
Institutions
11.4.1.2.4. Others
11.4.2. The UK
11.4.2.1. The
UK DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and Forecasts,
By Offerings
11.4.2.1.1. DEL-Driven
Hit identification
11.4.2.1.2. Hit-to-Lead
11.4.2.1.3. Lead
Optimization
11.4.2.1.4. Libraries
design and production
11.4.2.1.5. Screening
and data analysis
11.4.2.1.6. Others
11.4.2.2. The
UK DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.2.2.1. Pharmaceutical
Companies
11.4.2.2.2. Biotechs
11.4.2.2.3. Research
Institutions
11.4.2.2.4. Others
11.4.3. Spain
11.4.3.1. Spain
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.4.3.1.1. DEL-Driven
Hit identification
11.4.3.1.2. Hit-to-Lead
11.4.3.1.3. Lead
Optimization
11.4.3.1.4. Libraries
design and production
11.4.3.1.5. Screening
and data analysis
11.4.3.1.6. Others
11.4.3.2. Spain
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.3.2.1. Pharmaceutical
Companies
11.4.3.2.2. Biotechs
11.4.3.2.3. Research
Institutions
11.4.3.2.4. Others
11.4.4. Germany
11.4.4.1. Germany
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.4.4.1.1. DEL-Driven
Hit identification
11.4.4.1.2. Hit-to-Lead
11.4.4.1.3. Lead
Optimization
11.4.4.1.4. Libraries
design and production
11.4.4.1.5. Screening
and data analysis
11.4.4.1.6. Others
11.4.4.2. Germany
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.4.2.1. Pharmaceutical
Companies
11.4.4.2.2. Biotechs
11.4.4.2.3. Research
Institutions
11.4.4.2.4. Others
11.4.5. Italy
11.4.5.1. Italy
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.4.5.1.1. DEL-Driven
Hit identification
11.4.5.1.2. Hit-to-Lead
11.4.5.1.3. Lead
Optimization
11.4.5.1.4. Libraries
design and production
11.4.5.1.5. Screening
and data analysis
11.4.5.1.6. Others
11.4.5.2. Italy
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.5.2.1. Pharmaceutical
Companies
11.4.5.2.2. Biotechs
11.4.5.2.3. Research
Institutions
11.4.5.2.4. Others
11.4.6. Nordic
Countries
11.4.6.1. Nordic
Countries DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
11.4.6.1.1. DEL-Driven
Hit identification
11.4.6.1.2. Hit-to-Lead
11.4.6.1.3. Lead
Optimization
11.4.6.1.4. Libraries
design and production
11.4.6.1.5. Screening
and data analysis
11.4.6.1.6. Others
11.4.6.2. Nordic
Countries DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
11.4.6.2.1. Pharmaceutical
Companies
11.4.6.2.2. Biotechs
11.4.6.2.3. Research
Institutions
11.4.6.2.4. Others
11.4.6.3. Nordic
Countries DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux
Union DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.4.7.1.1. DEL-Driven
Hit identification
11.4.7.1.2. Hit-to-Lead
11.4.7.1.3. Lead
Optimization
11.4.7.1.4. Libraries
design and production
11.4.7.1.5. Screening
and data analysis
11.4.7.1.6. Others
11.4.7.2. Benelux
Union DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.4.7.2.1. Pharmaceutical
Companies
11.4.7.2.2. Biotechs
11.4.7.2.3. Research
Institutions
11.4.7.2.4. Others
11.4.7.3. Benelux
Union DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The
Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest
of Europe DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
11.4.8.1.1. DEL-Driven
Hit identification
11.4.8.1.2. Hit-to-Lead
11.4.8.1.3. Lead
Optimization
11.4.8.1.4. Libraries
design and production
11.4.8.1.5. Screening
and data analysis
11.4.8.1.6. Others
11.4.8.2. Rest
of Europe DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
11.4.8.2.1. Pharmaceutical
Companies
11.4.8.2.2. Biotechs
11.4.8.2.3. Research
Institutions
11.4.8.2.4. Others
11.5.Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Offerings
11.5.3. By
End-Users
12. Asia Pacific DNA-Encoded Libraries Platforms and Services
Market Analysis and Forecasts, 2021 - 2029
12.1.Overview
12.1.1. Asia
Pacific DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
12.2.Asia
Pacific DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
12.2.1. DEL-Driven
Hit identification
12.2.2. Hit-to-Lead
12.2.3. Lead
Optimization
12.2.4. Libraries
design and production
12.2.5. Screening
and data analysis
12.2.6. Others
12.3.Asia
Pacific DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.3.1. Pharmaceutical
Companies
12.3.2. Biotechs
12.3.3. Research
Institutions
12.3.4. Others
12.4.Asia
Pacific DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Country
12.4.1. China
12.4.1.1. China
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.1.1.1. DEL-Driven
Hit identification
12.4.1.1.2. Hit-to-Lead
12.4.1.1.3. Lead
Optimization
12.4.1.1.4. Libraries
design and production
12.4.1.1.5. Screening
and data analysis
12.4.1.1.6. Others
12.4.1.2. China
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.1.2.1. Pharmaceutical
Companies
12.4.1.2.2. Biotechs
12.4.1.2.3. Research
Institutions
12.4.1.2.4. Others
12.4.2. Japan
12.4.2.1. Japan
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.2.1.1. DEL-Driven
Hit identification
12.4.2.1.2. Hit-to-Lead
12.4.2.1.3. Lead
Optimization
12.4.2.1.4. Libraries
design and production
12.4.2.1.5. Screening
and data analysis
12.4.2.1.6. Others
12.4.2.2. Japan
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.2.2.1. Pharmaceutical
Companies
12.4.2.2.2. Biotechs
12.4.2.2.3. Research
Institutions
12.4.2.2.4. Others
12.4.3. India
12.4.3.1. India
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.3.1.1. DEL-Driven
Hit identification
12.4.3.1.2. Hit-to-Lead
12.4.3.1.3. Lead
Optimization
12.4.3.1.4. Libraries
design and production
12.4.3.1.5. Screening
and data analysis
12.4.3.1.6. Others
12.4.3.2. India
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.3.2.1. Pharmaceutical
Companies
12.4.3.2.2. Biotechs
12.4.3.2.3. Research
Institutions
12.4.3.2.4. Others
12.4.4. New
Zealand
12.4.4.1. New
Zealand DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
12.4.4.1.1. DEL-Driven
Hit identification
12.4.4.1.2. Hit-to-Lead
12.4.4.1.3. Lead
Optimization
12.4.4.1.4. Libraries
design and production
12.4.4.1.5. Screening
and data analysis
12.4.4.1.6. Others
12.4.4.2. New
Zealand DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.4.4.2.1. Pharmaceutical
Companies
12.4.4.2.2. Biotechs
12.4.4.2.3. Research
Institutions
12.4.4.2.4. Others
12.4.5. Australia
12.4.5.1. Australia
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.5.1.1. DEL-Driven
Hit identification
12.4.5.1.2. Hit-to-Lead
12.4.5.1.3. Lead
Optimization
12.4.5.1.4. Libraries
design and production
12.4.5.1.5. Screening
and data analysis
12.4.5.1.6. Others
12.4.5.2. Australia
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.5.2.1. Pharmaceutical
Companies
12.4.5.2.2. Biotechs
12.4.5.2.3. Research
Institutions
12.4.5.2.4. Others
12.4.6. South
Korea
12.4.6.1. South
Korea DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.6.1.1. DEL-Driven
Hit identification
12.4.6.1.2. Hit-to-Lead
12.4.6.1.3. Lead
Optimization
12.4.6.1.4. Libraries
design and production
12.4.6.1.5. Screening
and data analysis
12.4.6.1.6. Others
12.4.6.2. South
Korea DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.6.2.1. Pharmaceutical
Companies
12.4.6.2.2. Biotechs
12.4.6.2.3. Research
Institutions
12.4.6.2.4. Others
12.4.7. Southeast
Asia
12.4.7.1. Southeast
Asia DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.4.7.1.1. DEL-Driven
Hit identification
12.4.7.1.2. Hit-to-Lead
12.4.7.1.3. Lead
Optimization
12.4.7.1.4. Libraries
design and production
12.4.7.1.5. Screening
and data analysis
12.4.7.1.6. Others
12.4.7.2. Southeast
Asia DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.4.7.2.1. Pharmaceutical
Companies
12.4.7.2.2. Biotechs
12.4.7.2.3. Research
Institutions
12.4.7.2.4. Others
12.4.7.3. Southeast
Asia DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest
of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest
of Asia Pacific DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By Offerings
12.4.8.1.1. DEL-Driven
Hit identification
12.4.8.1.2. Hit-to-Lead
12.4.8.1.3. Lead
Optimization
12.4.8.1.4. Libraries
design and production
12.4.8.1.5. Screening
and data analysis
12.4.8.1.6. Others
12.4.8.2. Rest
of Asia Pacific DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By End-Users
12.4.8.2.1. Pharmaceutical
Companies
12.4.8.2.2. Biotechs
12.4.8.2.3. Research
Institutions
12.4.8.2.4. Others
12.5.Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Offerings
12.5.3. By
End-Users
13. Middle East and Africa DNA-Encoded Libraries Platforms and Services
Market Analysis and Forecasts, 2021 - 2029
13.1.Overview
13.1.1. Middle
East and Africa DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn)
13.2.Middle
East and Africa DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By Offerings
13.2.1. DEL-Driven
Hit identification
13.2.2. Hit-to-Lead
13.2.3. Lead
Optimization
13.2.4. Libraries
design and production
13.2.5. Screening
and data analysis
13.2.6. Others
13.3.Middle
East and Africa DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By End-Users
13.3.1. Pharmaceutical
Companies
13.3.2. Biotechs
13.3.3. Research
Institutions
13.3.4. Others
13.4.Middle
East and Africa DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi
Arabia DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.4.1.1.1. DEL-Driven
Hit identification
13.4.1.1.2. Hit-to-Lead
13.4.1.1.3. Lead
Optimization
13.4.1.1.4. Libraries
design and production
13.4.1.1.5. Screening
and data analysis
13.4.1.1.6. Others
13.4.1.2. Saudi
Arabia DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
13.4.1.2.1. Pharmaceutical
Companies
13.4.1.2.2. Biotechs
13.4.1.2.3. Research
Institutions
13.4.1.2.4. Others
13.4.2. UAE
13.4.2.1. UAE
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.4.2.1.1. DEL-Driven
Hit identification
13.4.2.1.2. Hit-to-Lead
13.4.2.1.3. Lead
Optimization
13.4.2.1.4. Libraries
design and production
13.4.2.1.5. Screening
and data analysis
13.4.2.1.6. Others
13.4.2.2. UAE
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
13.4.2.2.1. Pharmaceutical
Companies
13.4.2.2.2. Biotechs
13.4.2.2.3. Research
Institutions
13.4.2.2.4. Others
13.4.3. Egypt
13.4.3.1. Egypt
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.4.3.1.1. DEL-Driven
Hit identification
13.4.3.1.2. Hit-to-Lead
13.4.3.1.3. Lead
Optimization
13.4.3.1.4. Libraries
design and production
13.4.3.1.5. Screening
and data analysis
13.4.3.1.6. Others
13.4.3.2. Egypt
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
13.4.3.2.1. Pharmaceutical
Companies
13.4.3.2.2. Biotechs
13.4.3.2.3. Research
Institutions
13.4.3.2.4. Others
13.4.4. Kuwait
13.4.4.1. Kuwait
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.4.4.1.1. DEL-Driven
Hit identification
13.4.4.1.2. Hit-to-Lead
13.4.4.1.3. Lead
Optimization
13.4.4.1.4. Libraries
design and production
13.4.4.1.5. Screening
and data analysis
13.4.4.1.6. Others
13.4.4.2. Kuwait
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
13.4.4.2.1. Pharmaceutical
Companies
13.4.4.2.2. Biotechs
13.4.4.2.3. Research
Institutions
13.4.4.2.4. Others
13.4.5. South
Africa
13.4.5.1. South
Africa DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.4.5.1.1. DEL-Driven
Hit identification
13.4.5.1.2. Hit-to-Lead
13.4.5.1.3. Lead
Optimization
13.4.5.1.4. Libraries
design and production
13.4.5.1.5. Screening
and data analysis
13.4.5.1.6. Others
13.4.5.2. South
Africa DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
13.4.5.2.1. Pharmaceutical
Companies
13.4.5.2.2. Biotechs
13.4.5.2.3. Research
Institutions
13.4.5.2.4. Others
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest
of Middle East & Africa DNA-Encoded Libraries Platforms and Services Market
Revenue (US$ Mn) and Forecasts, By Offerings
13.4.6.1.1. DEL-Driven
Hit identification
13.4.6.1.2. Hit-to-Lead
13.4.6.1.3. Lead
Optimization
13.4.6.1.4. Libraries
design and production
13.4.6.1.5. Screening
and data analysis
13.4.6.1.6. Others
13.4.6.2. Rest
of Middle East & Africa DNA-Encoded Libraries Platforms and Services Market
Revenue (US$ Mn) and Forecasts, By End-Users
13.4.6.2.1. Pharmaceutical
Companies
13.4.6.2.2. Biotechs
13.4.6.2.3. Research
Institutions
13.4.6.2.4. Others
13.5.Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Offerings
13.5.3. By
End-Users
14. Latin America DNA-Encoded Libraries Platforms and Services
Market Analysis and Forecasts, 2021 - 2029
14.1.Overview
14.1.1. Latin
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
14.2.Latin
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.2.1. DEL-Driven
Hit identification
14.2.2. Hit-to-Lead
14.2.3. Lead
Optimization
14.2.4. Libraries
design and production
14.2.5. Screening
and data analysis
14.2.6. Others
14.3.Latin
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By End-Users
14.3.1. Pharmaceutical
Companies
14.3.2. Biotechs
14.3.3. Research
Institutions
14.3.4. Others
14.4.Latin
America DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn)
and Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.4.1.1.1. DEL-Driven
Hit identification
14.4.1.1.2. Hit-to-Lead
14.4.1.1.3. Lead
Optimization
14.4.1.1.4. Libraries
design and production
14.4.1.1.5. Screening
and data analysis
14.4.1.1.6. Others
14.4.1.2. Brazil
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
14.4.1.2.1. Pharmaceutical
Companies
14.4.1.2.2. Biotechs
14.4.1.2.3. Research
Institutions
14.4.1.2.4. Others
14.4.2. Argentina
14.4.2.1. Argentina
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.4.2.1.1. DEL-Driven
Hit identification
14.4.2.1.2. Hit-to-Lead
14.4.2.1.3. Lead
Optimization
14.4.2.1.4. Libraries
design and production
14.4.2.1.5. Screening
and data analysis
14.4.2.1.6. Others
14.4.2.2. Argentina
DNA-Encoded Libraries Platforms and Services Market Revenue (US$ Mn) and
Forecasts, By End-Users
14.4.2.2.1. Pharmaceutical
Companies
14.4.2.2.2. Biotechs
14.4.2.2.3. Research
Institutions
14.4.2.2.4. Others
14.4.3. Rest of
Latin America
14.4.3.1. Rest
of Latin America DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By Offerings
14.4.3.1.1. DEL-Driven
Hit identification
14.4.3.1.2. Hit-to-Lead
14.4.3.1.3. Lead
Optimization
14.4.3.1.4. Libraries
design and production
14.4.3.1.5. Screening
and data analysis
14.4.3.1.6. Others
14.4.3.2. Rest
of Latin America DNA-Encoded Libraries Platforms and Services Market Revenue
(US$ Mn) and Forecasts, By End-Users
14.4.3.2.1. Pharmaceutical
Companies
14.4.3.2.2. Biotechs
14.4.3.2.3. Research
Institutions
14.4.3.2.4. Others
14.5.Key Segment
for Channeling Investments
14.5.1. By
Country
14.5.2. By
Offerings
14.5.3. By
End-Users
15. Competitive Benchmarking
15.1.Market
Share Analysis, 2020
15.2.Global
Presence and Growth Strategies
15.2.1. Mergers
and Acquisitions
15.2.2. Product
Launches
15.2.3. Investments
Trends
15.2.4. R&D
Initiatives
16. Player Profiles
16.1.Amgen Inc.
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2.BOC
Sciencehunts
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT Analysis
16.2.7. Business
Strategies
16.3.DyNAbind
GmbH
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4.HitGen
Inc.
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5.LGC
Biosearch Technologies
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6.NovAliX
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7.Novartis
AG
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key
Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8.SpiroChem
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9.Vipergen
ApS
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key
Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10.WuXi
AppTec
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT
Analysis
16.10.7. Business
Strategies
16.11.X-Chem
16.11.1. Company
Details
16.11.2. Company
Overview
16.11.3. Product
Offerings
16.11.4. Key
Developments
16.11.5. Financial
Analysis
16.11.6. SWOT
Analysis
16.11.7. Business
Strategies
16.12.Other
Market Participants
17. Key Findings
Note: This
ToC is tentative and can be changed according to the research study conducted
during the course of report completion.
**Exclusive
for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
